Virologic Failure and Drug Resistance After Programmatic Switching to Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia
2024 · Clinical Infectious Diseases · 16 citations
https://doi.org/10.1093/cid/ciae261
Lighthouse Trust(MW)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
87
Citations
5
h-index
4
i10-index
Geldert Chiwaya is an academic researcher from Lighthouse Trust. The author has contributed to research in topics: HIV/AIDS Research and Interventions & Mobile Health and mHealth Applications & ICT in Developing Communities. The author has an h-index of 5, co-authored 13 publications.
https://doi.org/10.1093/cid/ciae261
https://doi.org/10.1101/2024.11.02.24316629
Click to start Chat